Clinician's Roundtable

Host: Bruce Japsen Guest: Kathleen Jaeger, JD Some of the most expensive drugs in the country are derived from biotechnology. But there is no law or regulatory pathway at the Food and Drug Administration to allow for cheaper biotech drugs such as those derived from chemicals like cholesterol pills or arthritis tablets with which doctors and their patients have become so familiar. Kathleen Jaeger,...

Host: Bruce Bloom, DDS, JD Guest: Ophir Klein, MD, PhD Where do we stand with stem cell research, and what does the future hold for this controversial field of investigation? Host Dr. Bruce Bloom discusses stem cell research with Dr. Ophir Klein, of the Biomedical Sciences Graduate Program at the University of California, San Francisco.

Host: Bruce Bloom, DDS, JD Guest: Ophir Klein, MD, PhD What are the mechanisms behind animal tooth regeneration, and what can tooth stem cell research tell us? Your host, Dr. Bruce Bloom and Dr. Ophir Klein, of the Biomedical Sciences Graduate Program at the University of California, San Francisco discuss stem cell research and the potential clinical applications pointed to by the study of the mou...

Host: Bruce Bloom, DDS, JD Guest: Ophir Klein, MD, PhD Dr. Ophir Klein, of the Biomedical Sciences Graduate Program at the University of California, San Francisco discusses his research on the mouse incisor and its continual growth correlated with stem cells, with your host, Dr. Bruce Bloom. Listen in as the Dr. Klein explores the world of stem cell research on the mouse incisor as related to over...

Host: Gary Kohn, MD Guest: Merrill Goozner As Massachusetts moves to authorize a mandate on individual health insurance, are these efforts hamstrung by state-level conflicts of interest? Will similar conflicts arise on the national level? Merrill Goozner, director of the Integrity in Science Project at the Center for Science in the Public Interest, addresses several obstacles to universal health c...

Host: Larry Kaskel, MD Guest: Owen J. Dahl, MBA Have you thought about speaking out, taking action to help reform our healthcare system? What can you do? Where do you begin? How can you make a difference? In this segment medical practice management consultant Owen Dahl talks to host Dr. Larry Kaskel about the steps a physician can take and the specific channels he can use to make a difference in h...

Host: Larry Kaskel, MD Guest: Owen J. Dahl, MBA What are the greatest challenges in your practice? Is it collections? Or possibly conflicts between your staff? Most likely the greatest challenges don’t have to do with doctoring. Is it time to call in a consultant to help you manage costs effectively and move on? Join host Dr. Larry Kaskel with practice consultant Owen Dahl as they discuss the role...

Host: Mark Nolan Hill, MD Guest: Jawed Fareed, PhD The FDA has issued an extensive recall on several contaminated heparin products, problems which have been traced back to ingredients from China, which were so similar to heparin that the contaminants fooled standard quality testing. Dr. Jawed Fareed, professor of pathology and pharmacology at Loyola University Chicago Stritch School of Medicine, d...

Host: Mark Nolan Hill, MD Guest: Jawed Fareed, PhD The FDA has issued an extensive recall on several contaminated heparin products, problems which have been traced back to ingredients from China. Dr. Jawed Fareed, professor of pathology and pharmacology at Loyola University Chicago Stritch School of Medicine, takes us through the process of heparin production, starting with the initial derivation...

Host: Mark Nolan Hill, MD Guest: Jawed Fareed, PhD The FDA has issued an extensive recall on several contaminated heparin products, problems which have been traced back to ingredients from China. Dr. Jawed Fareed, professor of pathology and pharmacology at Loyola University Chicago Stritch School of Medicine, has conducted tests on heparin batches since adverse effects from the drug were first rep...

Host: Mark Nolan Hill, MD Guest: Jawed Fareed, PhD The FDA has issued an extensive recall on several contaminated heparin products. What is the contaminant, and what medical problems and risks may be linked to the contaminated heparin? Dr. Jawed Fareed, professor of pathology and pharmacology at Loyola University Chicago Stritch School of Medicine, has conducted tests on heparin batches since adve...

Host: Bill Rutenberg, MD Guest: Robert Wagner, MD Whether to admit or observe a ER patient is not always clear cut. What criteria should you use to make this decision? How can you be sure that your decision process will be supported and covered by CMS? What if CMS isn’t ultimately willing to pay for the services? Join host Dr. Bill Rutenberg in conversation with Dr. Robert Wagner, Director and CMO...

Host: Bill Rutenberg, MD Guest: Robert Wagner, MD Most doctors don’t spend time memorizing Medicare and Medicaid compliance guidelines. Yet, they are often under the gun to make decisions based on reimbursement guidelines. In this segment, Dr. Bill Rutenberg learns about a new program available from Accretive Health called the Sure Decision Clinical Compliance Program where 'on call' doctors verse...

Host: Susan Dolan, RN, JD Guest: David Feldman, PhD Dr. David Feldman is assistant professor of counseling psychology at Santa Clara University. Hear Dr. Feldman as he discusses his research and clinical practice involving the role of hope in psychotherapy.

Host: Susan Dolan, RN, JD Guest: David Feldman, PhD Dr. David Feldman is assistant professor of counseling psychology at Santa Clara University and coauthor of the End of Life Handbook and many articles on his research regarding hope. Hear Dr. Feldman as he discusses CR Snyders Hope Theory and the Hope Scale.

Host: Susan Dolan, RN, JD Guest: David Feldman, PhD Dr. David Feldman is the coauthor of the End of Life Handbook and many articles on hope. Hear Dr. Feldman as he discusses the historical and current research on hope.

Host: Lee Freedman, MD Guest: Shelley Salpeter, MD Can metformin safely improve metabolic variables such as weight, lipids, fasting glucose and onset of outright diabetes? Will the improvement in these surrogate endpoints translate into fewer events? Dr. Shelley Salpeter joins host Dr. Lee Freedman to review the rationale for and data behind using metformin in high risk individuals to prevent the...

Host: Mark Nolan Hill, MD Guest: Nathaniel Soper, MD Innovations in minimally invasive surgery and endoscopy platforms are contributing to a promising procedural field called Natural Orifice Translumenal Endoscopic Surgery (NOTES). Dr. Nathaniel Soper, professor and chair of surgery at Northwestern University Feinberg School of Medicine, and one of the first surgeons in the United States to perfor...

Host: Mark Nolan Hill, MD Guest: Nathaniel Soper, MD Innovations in minimally invasive surgery and endoscopy platforms are contributing to a promising procedural field called Natural Orifice Translumenal Endoscopic Surgery (NOTES). Dr. Nathaniel Soper, professor and chair of surgery at Northwestern University Feinberg School of Medicine, and one of the first surgeons in the United States to perfor...

Host: Mark Nolan Hill, MD Guest: Nathaniel Soper, MD Innovations in minimally invasive surgery and endoscopy platforms are contributing to a promising procedural field called Natural Orifice Translumenal Endoscopic Surgery (NOTES). Which patients are the most likely candidates for NOTES procedures? Dr. Nathaniel Soper, professor and chair of surgery at Northwestern University Feinberg School of Me...

Host: Mark Nolan Hill, MD Guest: Nathaniel Soper, MD Innovations in minimally invasive surgery and endoscopy platforms are contributing to a promising procedural field called Natural Orifice Translumenal Endoscopic Surgery (NOTES). Dr. Nathaniel Soper, professor and chair of surgery at Northwestern University Feinberg School of Medicine, and one of the first surgeons in the United States to perfor...

Host: Maurice Pickard, MD Guest: Andrew Vickers, PhD How does the scientific researcher open his data yet still protect himself and advance his career? Dr. Andrew Vickers talks about data access, data sharing and the lack of a code of conduct for physicians releasing data. He reminds us that many scientific advances would not have occurred if not for shared data. Join host Dr. Maurie Pickard for a...

Host: Maurice Pickard, MD Guest: Andrew Vickers, PhD Dr. Andrew Vickers discusses the continuing trend of medical reseachers refusing to release raw data after publication. What impact does this make on delaying the advancement of science? Are doctors viewing these results as their personal property? Is there a danger that the public's perception will be that clinical trials are for the benefit of...

Host: Paul Raeburn Guest: Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma This special report from the 2008 American College of Cardiology conference features highlights of several leading research studies unveiled at the meeting, including the first release of scientific details of the ENHANCE trial. Several leading cardiologists, including ENHANCE trial principal investigator...

Host: Susan Dolan, RN, JD Guest: David Feldman, PhD Guest: Andrew Lasher, MD During this segment, Dr. David Feldman and Dr. Andrew Lasher offer expert advice about end-of-life care from their book, The End-of-Life Handbook. Susan Dolan hosts.